Nitrite reductase from Pseudomonas aeruginosa released by antimicrobial agents and complement induces interleukin-8 production in bronchial epithelial cells

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 4, 1999, Pages 794-801

  Sar, Borann ^a   Oishi, Kazunori ^a   Wada, Akihiro ^a   Hirayama, Toshiya ^a   Matsushima, Kouji ^b   Nagatake, Tsuyoshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL ENZYME; CEFTAZIDIME; GENTAMICIN; IMIPENEM; IMMUNOGLOBULIN G; INTERLEUKIN 8; LEVOFLOXACIN; NITRITE REDUCTASE;

ARTICLE; BACTERICIDAL ACTIVITY; BRONCHUS MUCOSA; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION;

EID: 0032945629     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.4.794     Document Type: Article

References (43)

1. Arditi, M., and J. Zhou. 1997. Differential antibiotic-induced endotoxin release and interleukin-6 production by human umbilical vein endothelial cells (HUVECs): amplification of the response by coincubation of HUVECs and blood cells. J. Infect. Dis. 175:1255-1258.
2. Atlas, R. M. 1993. M9 medium, p. 529. In L. C. Parks (ed.), Handbook of microbiological media. CRC Press, Boca Raton, Fla.
3. Benoni, G., L. Cuzzolin, C. Bertrand, V. Pucchetti, and G. Velo. 1987. Penetration of imipenem-cilastatin into the lung tissue and pericardial fluid of thoracotomized patients. Chemotherapia 6(Suppl. 1):259-260.
4. Bryan, C. S., and K. L. Reynolds. 1984. Bacteremic nosocomial pneumonia. Am. Rev. Respir. Dis. 129:668-671.
5. Chollet-Martin, S., B. Jourdain, C. Gibert, C. Elbim, J. Chastre, and M. A. Gougerot-Pocidalo. 1996. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am. J. Respir. Crit. Care Med. 153: 594-601.
6. Committee for the Susceptibility of Antimicrobial Agents. 1992. A report from the Committee for the Susceptibility of Antimicrobial Agents. Japanese Society of Chemotherapy, Tokyo, Japan.
7. Cooper, N. R., and G. R. Nemerow. 1989. Complement and infectious agents: a tale of disguise and deception. Complement Inflamm. 6:249-258.
8. Davis, B. D., L. Chen, and P. C. Tai. 1986. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc. Natl. Acad. Sci. USA 83:6164-6168.
9. Di Mango, E., H. J. Zar, R. Byran, and A. Prince. 1995. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J. Clin. Investig. 96:2204-2210.
10. Fick, R. B. 1989. Pathogenesis of the Pseudomonas lung infection in cystic fibrosis. Clinical implication of basic research. Chest 96:158-154.
11. Fick, R. B., R. A. Robbins, S. U. Squier, W. E. Schoderbe, and W. D. Russ. 1986. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation C5a and chemotactic activity. Pediatr. Res. 20:1258-1268.
12. Fontán, P. A., C. R. Amura, V. E. Garcia, M. C. Cerquetti, and D. O. Sordelli. 1992. Preliminary characterization of Pseudomonas aeruginosa peptide chemotactins for polymorphonuclear leukocytes. Infect. Immun. 60: 2465-2469.
13. Jackson, J. J., and H. Kropp. 1992. β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP3-specific ceftazidime. J. Infect. Dis. 165:1033-1041.
14. Junger, W. G., T. A. Cardoza, F. C. Liu, D. B. Hoyt, and R. Goodwin. 1993. Improved rapid photometric assay for quantitative measurement of PMN migration. J. Immunol. Methods 160:73-79.
15. Kirikae, T., F. Kirikae, S. Saito, K. Tominaga, H. Tamura, Y. Uemura, T. Yokochi, and M. Nakano. 1998. Biological characterization of endotoxins released from antibiotic-treated Pseudomonas aeruginosa and Escherichia coli. Antimicrob. Agents. Chemother. 42:1015-1021.
16. Ko, Y., N. Mukaida, A. Panyutich, N. N. Voitenok, K. Matsushima, T. Kawai, and T. Kasahara. 1991. A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J. Immunol. Methods 149:227-235.
17. Kruger, T., and J. Baier. 1997. Induction of neutrophil chemoattractant cytokines by Mycoplasma hominis in alveolar type II cells. Infect. Immun. 65: 5131-5136.
18. Masaki, H., K. Matsumoto, K. Watanabe, S. Mitarai, M. Tao, K. Oishi, T. Terazono, T. Yoshida, A. Iwagaki, and T. Nagatake. 1992. In vitro antibacterial activity, penetration into sputum, and clinical evaluation of levofloxacin in chronic respiratory tract infection. Chemotherapy 40(Suppl. 3):336-347.
19. Massion, P. P., H. Inoue, J. Richman-Eisenstat, D. Grunberger, P. G. Jorens, B. Housset, J.-F. Pittet, J. P. Wiener-Kronish, and J. A. Nadel. 1994. Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J. Clin. Investig. 93:26-32.
20. Matsumoto, K., T. Harada, H. Shishido, Y. Uzuka, T. Nagatake, N. Rikitomi, K. Oishi, and K. Watanabe. 1983. Laboratory and clinical evaluation on ceftazidime with special reference to respiratory infections caused by Pseudomonas aeruginosa. Chemotherapy 31(Suppl. 3):434-446.
21. McKinnon, K. P., M. C. Madden, T. L. Noah, and R. B. Devlin. 1993. In vitro ozon exposure increases release of arachidonic acid products from a human bronchial epithelial cell line. Toxicol. Appl. Pharmacol. 118:215-223.
22. Miller, E. J., A. B. Cohen, and M. A. Matthay. 1996. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit. Care Med. 24:1448-1454.
23. Mori, N., B. Sar, and K. Oishi. Unpublished data.
24. Nakamura, H., K. Yoshimura, H. A. Jaffe, and R. G. Crystal. 1991. Interleukin-8 gene expression in human bronchial epithelial cells. J. Biol. Chem. 266:19611-19617.
25. Nakano, M., and T. Kirikae. 1996. Biological characterization of Pseudomonas aeruginosa endotoxin release by antibiotic treatment in vitro. J. Endotoxin Res. 3:195-200.
26. Odio, W., E. Van Laer, and J. Klastersky. 1975. Concentrations of gentamicin in bronchial secretions after intramuscular and endotracheal administration. J. Clin. Pharmacol. 15:518-524.
27. Oishi, K., B. Sar, A. Wada, Y. Hidaka, S. Matsumoto, H. Amano, F. Sonoda, S. Kobayashi, T. Hirayama, T. Nagatake, and K. Matsushima. 1997. Nitrite reductase from Pseudomonas aeruginosa induces inflammatory cytokines in cultured respiratory cells. Infect. Immun. 65:2648-2655.
28. Oishi, K., F. Sonoda, S. Kobayashi, A. Iwagaki, T. Nagatake, K. Matsushima, and K. Matsumoto. 1994. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect. Immun. 62:4145-4152.
29. Oishi, K., K. L. Nancy, G. Guelde, and M. Pollack. 1992. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity. J. Infect. Dis. 165:34-45.
30. Pennington, J. E., H. Y. Reynolds, and P. P. Carbone. 1973. Pseudomonas pneumonia. A retrospective study of 36 cases. Am. J. Med. 55:155-160.
31. Pier, G. B., and P. Ames. 1984. Mediation of the killing of rough, mucoid isolates of Pseudomonas aeruginosa from patients with cystic fibrosis by alternative pathway of complement. J. Infect. Dis. 150:223-228.
32. Pollack, M. 1984. The virulence of Pseudomonas aeruginosa. Rev. Infect. Dis. 6:S617-S626.
33. Ponglertnapagorn, P., K. Oishi, A. Iwagaki, F. Sonoda, K. Watanabe, T. Nagtake, and K. Matsumoto. 1996. Airway interleukin-8 in elderly patients with bacterial lower respiratory tract infections. Microbiol. Immunol. 40: 177-182.
34. Prins, J. M., M. A. van Agtmael, E. J. Kuijper, S. J. H. van Deventer, and P. Speelman. 1995. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J. Infect. Dis. 172:886-891.
35. Rodriguez, J. L., C. G. Miller, L. E. DeForge, L. Kelty, C. J. Shanley, R. H. Bartlett, and D. G. Remick. 1992. Local production of interleukin-8 is associated with nosocomial pneumonia. J. Trauma 33:74-82.
36. Samet, J. M., and M. C. Madden. 1996. Characterization of a secretory phospholipase A2 in human bronchoalveolar lavage fluid. Exp. Lung Res. 22: 299-315.
37. Schiller, N. L., and K. A. Joiner. 1986. Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa. Infect. Immun. 54:689-694.
38. Silvestrini, M. C., C. L. Galeotti, M. Gervais, E. Schinina, D. Barra, F. Bossa, and M. Brunori. 1989. Nitrite reductase from Pseudomonas aeruginosa: sequence of the gene and the protein. FEBS Lett. 254:33-38.
39. Sonoda, F., K. Oishi, H. Tanaka, H. Miwa, S. Kobayashi, T. Nagatake, and K. Matsumoto. 1991. Serum sensitivity of Pseudomonas aeruginosa isolated from sputum as a virulence factor in the lower respiratory tract. Jpn. J. Thorac. Dis. 29:703-709.
40. Striz, I., T. Mio, Y. Adachi, V. Bazil, and S. Rennard. 1998. The CD14 molecule participates in regulation of IL-8 and IL-6 release by bronchial epithelial cells. Immunol. Lett. 62:177-181.
41. Takahashi, K., K. Narita, Y. Kato, T. Sugiyama, N. Koide, T. Yoshida, and T. Yokochi. 1997. Low-level release of Shiga-like toxin (verocytotoxin) and endotoxin from enterohemorrhagic Escherichia coli treated with imipenem. Antimicrob. Agents Chemother. 41:2295-2296.
42. Van den Berg, C., A. J. De Neeling, C. S. Schot, W. N. M. Hustinx, J. Wemer, and D. J. De Wildt. 1992. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand. J. Infect. Dis. 24:619-627.
43. Winer-Muram, H. T., S. G. Jennings, R. G. Wunderink, C. B. Jones, and K. V. Leeper, Jr. 1995. Ventilator-associated Pseudomonas aeruginosa pneumonia: radiographic findings. Radiology 195:247-252.